CASE REPORT BLEPHAROCONJUNCTIVITIS AS MANIFESTATION OF STEVENSJOHNSON SYNDROME

Authors

  • Putu Ayu Adindhya Saraswati Surya Udayana University
  • Ni Nyoman Sunariasih

DOI:

https://doi.org/10.33086/mhsj.v5i2.2189

Keywords:

Blepharoconjunctivitis, Conjunctivitis, Stevens-Johnson syndrome, SJS, Ocular Manifestation

Abstract

Background: Stevens Johnson syndrome (SJS) is a collection of acute and life threatening skin symptoms caused by an allergic drug reaction. SJS also attacks the other mucous membranes, one of which is the eye. SJS is a rare case. The initial complaint of SJS is the eruption on the skin in the form of redness followed by blisters and attacking other mucous membranes. The ocular manifestations of SJS are conjunctivitis, corneal erosion, corneal ulcers, and blepharitis.

Methods: Treatment of SJS’s ocular manifestation is administration of drugs and surgical intervention. Administration of drugs that often done in the acute phase is antibiotic eye drops with steroids to prevent complications. Complications that can occur include symblepharon, districhiasis, and keratitis. This complication can cause a sharp decrease in vision.

Results: This case report discusses a 68 year old male patient with blisters all over his body accompanied by swelling in both eyes, redness in both eyes, and difficult to open eyes. Patients with history of taking the new drug a month ago. No history of drug allergy. The patient suffered from hypertension, non-hemorrhagic stroke, and epilepsy with irregular treatment. Patient was performed a fluorescein test. In this case, the patient is given antibiotic ointment and artificial tears with steroids. In this case there were no complications.

Conclusion: The ocular manifestations of SJS if handled quickly and properly can prevent long-term complications.

Downloads

Download data is not yet available.

References

Schwering MS, Kayange P, Rothe C. Ocular manifestations in patients with Stevens–Johnson syndrome in Malawi—review of the literature illustrated by clinical cases. Graefe's Archive for Clinical and Experimental Ophthalmology. 2019; 257: 2343–2348.

Putri ND, Mutiara H, Hasudungan, Sibero HT, Sukohar A. Steven-Johnson Syndrom et causa Paracetamol. Medula Unila. 2016; 6(1).

Fitriana A, Endaryanto A, Hidayati AN. Gambaran Klinis Steven Johnson Syndrome dan Toxic Epidermal Necrolysis pada Pasien Anak. Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology. 2018; 30(2).

Chow LLW, Shih KC, Chan JCY, Lai JSM, Ng ALK. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. BMC Ophthalmology. 2017; 17:65.

Jenkins P, Enurah A, Scherbak D. A case report of ocular Stevens-Johnson syndrome: An important condition for the internist to see. Int J Acad Med. 2020; 6:33-5.

Salmon JF. Kanski’s Clinical Ophthalmology: A Systematic Approach. Conjunctivitis In Blistering Mucocutaneous Disease. 9th Ed. China: Elselvier; 2020. p. 189-193

Wang JW, Rixen JJ, Goins KM, Kitzmann AS. Ocular Manifestations of Stevens-Johnson Syndrome: 13-year-old female with mucosal and dermatologic eruptions. EyeRounds; 2014. [Cited 2021 Feb 18]. Available from http://EyeRounds.org/cases/192-Stevens-Johnson.htm

Abrol A, Gulanikar A, Thakre S, Patel A. Study of Ocular Manifestations of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Indian Dermatol Online J. 2020 Jul-Aug; 11(4): 570–574.

Saeed HN, Rashad R. Foundations of Corneal Disease. In: Colby K, Dana R, editors. Ocular Disease in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Springer Nature Switzerland AG. 2020; 97-108.

Pandiaraj SSV. Vigilant Treatment and Early Intervention Of Ocular Manifestations Of Steven Johnson Syndrome. University Journal of Surgery and Surgical Specialities. 2017; 3(4).

Downloads

Published

2021-09-23

How to Cite

Saraswati Surya, P. A. A. ., & Sunariasih, N. N. . (2021). CASE REPORT BLEPHAROCONJUNCTIVITIS AS MANIFESTATION OF STEVENSJOHNSON SYNDROME. Medical and Health Science Journal, 5(2), 38–44. https://doi.org/10.33086/mhsj.v5i2.2189

Issue

Section

Articles